These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 807637)
1. Host defenses against influenza virus: the role of anti-hemagglutinin antibody. Virelizier JL J Immunol; 1975 Aug; 115(2):434-9. PubMed ID: 807637 [TBL] [Abstract][Full Text] [Related]
2. The effect of T lymphocyte depletion on susceptibility to influenza virus infection and development of anti-viral immunity in lethally irradiated mice reconstituted with syngeneic bone marrow grafts. Mumcuoglu M; Zakay-Rones Z; Parag G; Weiss L; Slavin S Bone Marrow Transplant; 1987 Dec; 2(4):403-12. PubMed ID: 3332187 [TBL] [Abstract][Full Text] [Related]
3. Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. Kris RM; Asofsky R; Evans CB; Small PA J Immunol; 1985 Feb; 134(2):1230-5. PubMed ID: 2981265 [TBL] [Abstract][Full Text] [Related]
4. A mouse model of influenza protection. Russell SM Dev Biol Stand; 1977 Jun 1-3; 39():397-403. PubMed ID: 604121 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities. Hurwitz JL; Herber-Katz E; Hackett CJ; Gerhard W J Immunol; 1984 Dec; 133(6):3371-7. PubMed ID: 6208279 [TBL] [Abstract][Full Text] [Related]
6. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus. Floc'h F; Werner GH Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787 [TBL] [Abstract][Full Text] [Related]
7. Effects of cell mediated immunity in influenza virus infection in mice. Schulman JL; Petigrow C; Woodruff J Dev Biol Stand; 1977 Jun 1-3; 39():385-90. PubMed ID: 304820 [TBL] [Abstract][Full Text] [Related]
8. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. Scherle PA; Palladino G; Gerhard W J Immunol; 1992 Jan; 148(1):212-7. PubMed ID: 1530795 [TBL] [Abstract][Full Text] [Related]
9. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168 [TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses. Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101 [TBL] [Abstract][Full Text] [Related]
11. Assessment of resistance to influenza virus infection in animal models. Potter CW; McLaren C; Jennings R Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574 [TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536 [TBL] [Abstract][Full Text] [Related]
13. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors. Janeway CA J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836 [TBL] [Abstract][Full Text] [Related]
14. Fusion of C3d with hemagglutinin enhances protective immunity against swine influenza virus. Li GX; Tian ZJ; Yu H; Jin YY; Hou SH; Zhou YJ; Liu TQ; Hu SP; Tong GZ Res Vet Sci; 2009 Jun; 86(3):406-13. PubMed ID: 19010505 [TBL] [Abstract][Full Text] [Related]
15. Maternal-infant transfer of influenza-specific immunity not detectable by haemagglutination inhibition. Reuman PD; Kris RM; Ayoub EM; Small PA Microbios; 1988; 54(220-221):135-47. PubMed ID: 2846987 [TBL] [Abstract][Full Text] [Related]
16. Do L3T4+ T cells act as effector cells in protection against influenza virus infection. Lightman S; Cobbold S; Waldmann H; Askonas BA Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868 [TBL] [Abstract][Full Text] [Related]
17. [Protective action of cytotoxic lymphocytes depending on the antigenic determinant composition of influenza virus hemagglutinin]. Berdinskikh MS; Kiseleva AS; Kosiakov PN Biull Eksp Biol Med; 1989 Oct; 108(10):471-2. PubMed ID: 2480826 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. Epstein SL; Lo CY; Misplon JA; Lawson CM; Hendrickson BA; Max EE; Subbarao K J Immunol; 1997 Feb; 158(3):1222-30. PubMed ID: 9013963 [TBL] [Abstract][Full Text] [Related]
19. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
20. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]